Skip to content

Alignment Healthcare ALHC Return on equity

Return on equity at other companies

Humana logo
HumanaHUM
18.2%+0.9pp
CVS Health logo
CVS HealthCVS
3.8%-3.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
11.8%-11.1pp
Elevance Health logo
Elevance HealthELV
12.1%-2.1pp
Molina Healthcare logo
Molina HealthcareMOH
19.7%-6.7pp
Centene logo
CenteneCNC
-26.1%-38.7pp

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%
Enterprise value$4.14B-6.7%
P/E228.2×
P/S1.1×-0.4×

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%

Returns & leverage

See full
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Alignment Healthcare’s reported figures.

Based on trailing twelve months.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alignment Healthcare's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alignment Healthcare's return on equity?
Alignment Healthcare (ALHC) reported return on equity of 12.6% in Q1 2026.
How has Alignment Healthcare's return on equity changed year-over-year?
Alignment Healthcare's return on equity increased by 116.6% year-over-year, from -75.8% to 12.6%.
What is the long-term trend for Alignment Healthcare's return on equity?
Over 4 years (2021 to 2025), Alignment Healthcare's return on equity has grown at a -74.1% compound annual growth rate (CAGR), from -116% to -0.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.